Each week, we feature a physician executive. This week's featured physician executive is Hal Barron, MD, Executive Vice President, Global Development and Chief Medical Officer, Genentech.
Here's some background about Dr. Barron from Businessweek:
Hal V. Barron M.D., FACC served as Executive Vice President of Global Development of Genentech, Inc. and its Chief Medical Officer since March 2004. Dr. Barron's academic positions at the University of California, San Francisco include Associate Adjunct Professor of Epidemiology and Biostatistics, and Associate Clinical Professor of Medicine/Cardiology. Dr. Barron joined Genentech Inc. in 1996 as a Clinical Scientist. He served as Senior Vice President of Development of Genentech Inc. since January 2004. During the next several years, he held positions as Head of Development, associate Director and Director of Cardiovascular Research and Senior Director of the Biotherapeutics group within Medical Affairs. In May 2002, he was promoted to Vice President of Medical Affairs. He leads the newly formed Development organization that is being created by combining Genentech's Medical Affairs and Development Sciences departments. The Development organization is responsible for pre-clinical, clinical, and post-approval activities. He has been issued several patents for his work in thrombosis and angiogenesis, and has published more than 90 papers in peer-reviewed scientific journals. He serves as a Director of Arête Therapeutics, Inc. He has been a Director of Alexza Pharmaceuticals Inc. since December 2007. Dr. Barron received his Medical Degree from Yale University and holds a Bachelor of Science in Physics from Washington University.